TD Asset Management Inc. Has $95.81 Million Stake in CME Group Inc. (NASDAQ:CME)

TD Asset Management Inc. lowered its holdings in CME Group Inc. (NASDAQ:CME) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 412,551 shares of the financial services provider’s stock after selling 7,858 shares during the quarter. TD Asset Management Inc. owned about 0.11% of CME Group worth $95,807,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. increased its holdings in shares of CME Group by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock valued at $7,952,273,000 after purchasing an additional 326,623 shares in the last quarter. Geode Capital Management LLC raised its position in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after acquiring an additional 142,692 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of CME Group during the fourth quarter valued at $871,063,000. Janus Henderson Group PLC lifted its stake in shares of CME Group by 17.8% during the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after acquiring an additional 380,071 shares during the period. Finally, Capital Wealth Planning LLC increased its position in CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares in the company, valued at $5,686,980. The trade was a 31.37 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,076 shares of company stock worth $6,871,496. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on CME. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Morgan Stanley raised their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Barclays lifted their price objective on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $238.93.

CME Group Stock Down 0.3 %

CME stock opened at $262.06 on Wednesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market capitalization of $94.44 billion, a P/E ratio of 27.10, a P/E/G ratio of 6.76 and a beta of 0.53. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $267.91. The business has a 50-day moving average of $247.77 and a 200-day moving average of $234.95.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group announced that its Board of Directors has initiated a stock repurchase plan on Thursday, December 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its stock is undervalued.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a $1.25 dividend. The ex-dividend date is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.91%. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is currently 51.71%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.